Johnson & Johnson
JNJ- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000200406
In the last 90 days, Johnson & Johnson insiders filed 0 open-market purchases and 6 sales; 4,701 institutions reported holding it in 13F filings for Q2 2026, worth $456.9B in total; 5 superinvestors hold it, including Markel Group and Fairfax Financial.
Q3 2021 vs. Q2 2021
How the institutions holding Johnson & Johnson changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 3,333 | 47 | 3,320 | +34 |
| Shares | 1.80B | 5.07M | 1.81B | +15.2M (+0.9%) |
| Value | $295.7B | $835.4M | $291.7B | −$3.12B (−1.1%) |
47 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (120)
Institutions that held Johnson & Johnson at the end of Q3 2021 but not at the end of Q2 2021.
Showing the largest 100 of 120 by value.
Sold out (86)
Institutions that held Johnson & Johnson at the end of Q2 2021 and filed for Q3 2021 without it.
Not filed for Q3 2021 yet (47)
Institutions that held Johnson & Johnson at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.